CME Program

CME Program

How to Obtain CME Credit

1) Click the button below to purchase this CME ($150):


2) View CME Program Videos:


3) Complete Post-Video Evaluation:


*Please remember, you must complete all three steps &
recieve a 90% on your evaluation to recieve CME Credit. 


When, Why, & How of Opioids:

New Guidelines on Treating Pain

Course Description: This module will provide a comprehensive description and explanation of the opioid epidemic, review of CDC guidelines and recommendations for non-opioid treatment of pain.

The Prescription Drug Epidemic originates not from outlier clinicians operating pill mills, but rather from a fundamental lack of training in pain across all healthcare fields. Special Interests and industries exploit this vacuum and fill it with miseducation that contradict scientific evidence, promote excessive & inappropriate prescribing, and create a false sense of security around opioids. In fact, until the CDC guidelines, nearly all opioid didactics have had an industry bias. All of this has been to the detriment of a vulnerable patient population, who in spite of (and often, as a result of) opioid use continue to live in pain and dysfunction.

This lecture series corrects many myths in managing pain. Clinicians of all specialties will better understand the pathophysiology of pain and the full effects of opioids. Without any industry support or bias, it further teaches Evidence-Based, sustainable options to managing patients’ pain.

Topics Covered:

  • Epidemiology of the Opioid Epidemic
  • The Special Interests that Overshadowed Science
  • CDC Guidelines & it’s Scientific Rationals
  • Paradigm Shift in Pain Treatment

Statement of Need: State regulations from the passage of House Bill1 requires continuing medical education around pain management and opioid prescribing. This has evolved from the dramatic rise in opioid overdoses across the nation which exceed over 25,000 individuals annual. As a result of the sheer volume of patients now managed by opioids, the most prescribed drug class in the country, the number of patients vulnerable to dependency, morbidity, and mortality is dangerously high. In the context of regulatory changes and new CDC guidelines, the number of clinicians willing to maintain patients is reduced and the burden of tapering the tens of thousands of Kentuckians already on an opioid exceeds the available clinicians managing pain. As such, clinicians across Kentucky need a better understanding of how to taper opioids, the alternatives to managing pain, a greater insight on when opioid initiation and management is appropriate.

Objectives:

  • Attendees will be able to describe the current prescription epidemic and its evolution
  • Attendees will challenge their own prescribing habits and medical beliefs which may have contributed to the evolution of opioid epidemic
  • Attendees will better discern what situations warrant INITIATION of opioids
  • Attendees will better understand the pathophysiology of the most common conditions for which opioids are prescribed and whether it’s use is appropriate
  • Attendees will be able to discuss the medical rational for opioid tapering with patients
  • Attendees will be able to taper opioids in a safe manner without excessively challenging patients
  • Attendees will better understand when to refer a patient and to what specialties

Target Audience:  Physicians practicing and prescribing opioid medications.

Estimated Time to Complete:  This module will take approximately 4.50 hours to complete. Click to purchase modules.

Method of Participation Used:  Participants will view and listen to a recorded lecture while simultaneously viewing slides and embedded videos. Click to view videos.

Evaluation Form:You will be asked to complete a post-test and score 90% or higher and complete a short survey monkey evaluation. Click to view survey. 

Hardware/Software Requirements:  High speed internet connection

Faculty:  Danesh Mazloomdoost, MD

Reviewer:  Miranda Mosley, KMA CME Committee

Disclosure:  All speakers disclose they have nothing to disclose.  All reviewers disclose they have nothing to disclose.

Commercial Support:  There is no commercial support associated with this activity

Accreditation and Designation:  This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Kentucky Medical Association and Wellward Regenerative Medicine. The Kentucky Medical Association is accredited by the ACCME to provide continuing medical education for physicians.

Approval:  This activity has been approved by the Kentucky Board of Medical Licensure to meet 4.50 credits of the requirement for House Bill 1.

Provider Contact Information:  Danesh Mazloomdoost, MD

Copyright:  There is no copyright associated with this activity

Release Date:  December 2017

Termination Date:  December 2019


Danesh Mazloomdoost, MD
Medical Director, Wellward Regenerative Medicine

A native Kentuckian, Dr. Danesh continues the legacy of his parents, two passionate physicians who build one of Kentucky’s first multidisciplinary pain clinics. As a fellowship-trained and dual-board certified Anesthesiologist & Pain Specialist, he trained at Johns Hopkins and MD Anderson. He returned home to Kentucky to help undo the problems in healthcare that have contributed to the opioid epidemic and ineffective pain management.